Links

  1. CReST2 is funded by the National Institute for Health Research (NIHR) Health Technology Programme. The NIHR is the most integrated clinical research system in the world, driving research from bench to bedside for the benefit of patients and the economy.
  2. CReST2 is part of the Birmingham Surgical Trials Consortium (BiSTC) portfolio. The BiSTC aims to enhance patient care by developing new surgical clinical trials, creating clinical networks, widening participation in trials, and training trialists of the future.   Follow CReST2 on the BiSTC Twitter account @bistc1.